1WANG GJ,CHUNG KC,SHEN WJ.Lipid clearing agents in steroid-induced osteoporosis[J].J Formosan Med Assoc,1995,94(10):589-592.
2CUI Q,WANG GJ,SU CC,et al.The Otto Aufranc Award.Lovastatin prevents steroid induced adipogenesis and osteonecrosis[J].Clin Orthop,1997,(344):8-19.
3MUNDY G,GARRETT R,HARRIS S,et al.Stimulation of bone formation in vitro and in rodents by statins[J].Science,1999,286(5446):1946-1949.
4SUGIYAMA M,KODAMA T,KONISHI K,et al.Compactin and simvastatin,but not pravastatin,induce bone morphogenetic protein-2 in human osteosarcoma cells[J].Biochem Biophys Res Commun,2000,271(3):688-692.
5MAEDA T,MATSUNUMA A,KAWANE T,et al.Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells[J].Biochem Biophys Res Commun,2001,280(3):874-877.
6CHAN KA,ANDRADE SE,BOLES M,et al.Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women[J].Lancet,2000,359(9222):2185-2188.
7MEIER CR,SCHLIENGER RG,KRAENZLIN ME,et al.HMG-CoA reductase inhibitors and the risk of fractures[J].JAMA,2000,283(24):3205-3210.
8WANG PS,SOLOMON DH,MOGUN H,et al.HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients[J].JAMA,2000,283(24):3211-3216.
9EDWARDS CJ,HART DJ,SPECTOR TD.Oral statins and increased bone-mineral density in postmenopausal women[J].Lancet,2000,355(9222):2218-2219.
10CHUNG YS,LEE MD,LEE SK,et al.HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients[J].J Clin Endocrinol Metab,2000,85(3):1137-1142.
9Mogensen CE, Schmitz A, Christensen CK. Comparative renal pathophysiology relevant to IDDM and NIDDM patients [ J]. Diabetes Metabol Rev, 1998,4 (5) :453-483.
10Levin SR, Comstock JP, Coburn JW, et al. Effect of intensive glycemic control on microalbumiuria in type 2 diabetes [ J ]. Diabetes Care ,2000,23 ( 10 ) : 1478-1485.
